Topical Hydroxycitrate and Carnitine for Sebum Reduction

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current solutions fail to effectively reduce sebum production in sebaceous glands, which leads to oily skin and greasy hair, a cosmetically undesirable condition that affects well-being, especially in young people and is often associated with acne.

Innovation Solution

Topical preparations containing Garcinia Cambogia Extract with hydroxycitrate and carnitine, in specific ratios, are applied to reduce sebum production, with hydroxycitrate content between 0.25% to 2% and carnitine content between 1% to 4%, demonstrating synergistic effects in sebum reduction.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If conventional preparations are used, then general skin benefits are provided, but sebum production is not effectively reduced

Engineering Contradiction:
Improvesebum reduction effectivenessVSAvoidcosmetic benefit delivery
Core Design Contradiction:
ReliabilityVSProductivity

Solution Approach 1:

The patent combines hydroxycitrate (from Garcinia Cambogia Extract) and carnitine in a topical preparation to achieve synergistic sebum reduction. This merging of two active ingredients with complementary mechanisms addresses the insufficiency of single-ingredient preparations in effectively reducing sebum production while maintaining skin health.

Inventive Principle:
Principle #5Merging (Combining)

Solution Approach 2:

The invention uses a composite formulation containing both hydroxycitrate and carnitine, leveraging their different mechanisms of action (fatty acid synthesis inhibition and fatty acid transport facilitation) to create a more effective sebum-reducing preparation than either ingredient alone could provide.

Inventive Principle:
Principle #40Composite materials

2Reliability

If hydroxycitrate and carnitine are combined in specific ratios, then synergistic sebum reduction is achieved, but formulation complexity increases

Engineering Contradiction:
Improvesebum reduction effectivenessVSAvoidpreparation formulation complexity
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent specifies optimal concentration ranges (hydroxycitrate: 0.01-5%, carnitine: 0.1-10%) and ratio ranges (1:10 to 10:1) to achieve synergistic effects. By defining these parameter windows, the invention balances the need for effective sebum reduction with the practicalities of formulation development and manufacturing.

Inventive Principle:
Principle #35Parameter changes

3Object-generated harmful factors

If sebum production is reduced, then oily skin and greasy hair are improved, but skin hydration may be affected

Engineering Contradiction:
Improveexcessive sebum productionVSAvoidskin lipids
Core Design Contradiction:
Object-generated harmful factorsVSLoss of substance

Solution Approach 1:

The patent selectively targets excessive sebum production by incorporating ingredients that inhibit fatty acid synthesis (hydroxycitrate) and facilitate fatty acid transport (carnitine), rather than stripping all lipids from the skin. This selective approach reduces harmful sebum while preserving necessary skin barrier lipids.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention converts the potential harm of sebum reduction (dryness) into a benefit by using ingredients that regulate sebum production rather than remove sebum. Hydroxycitrate inhibits excessive fatty acid synthesis, while carnitine helps transport fatty acids away from sebaceous glands, collectively reducing oily appearance while maintaining skin hydration balance.

Inventive Principle:
Principle #22Blessing in disguise (Convert harm into benefit)

Data Source

PatentEP2029094B1Use of preparations containing hydroxycitrate and carnitine as active principles for sebum reduction
Publication Date: 2011.10.26 BEIERSDORF AG
  • EP2029094B1 patent drawing
  • EP2029094B1 patent drawing

AI summary

Use of topical preparations comprising hydroxycitrate for reducing sebum production in the sebaceous gland.